Kaur A - Search Results

1

Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP; MEDAL Steering Committee. Laine L, et al. Among authors: kaur a. Lancet. 2007 Feb 10;369(9560):465-73. doi: 10.1016/S0140-6736(07)60234-7. Lancet. 2007. PMID: 17292766

2

Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines.

Laine L, Connors L, Griffin MR, Curtis SP, Kaur A, Cannon CP. Laine L, et al. Among authors: kaur a. Aliment Pharmacol Ther. 2009 Oct;30(7):767-74. doi: 10.1111/j.1365-2036.2009.04090.x. Epub 2009 Jul 7. Aliment Pharmacol Ther. 2009. PMID: 19594486 Clinical Trial.

3

Risk factors for NSAID-associated upper GI clinical events in a long-term prospective study of 34 701 arthritis patients.

Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP. Laine L, et al. Among authors: kaur a. Aliment Pharmacol Ther. 2010 Nov;32(10):1240-8. doi: 10.1111/j.1365-2036.2010.04465.x. Epub 2010 Sep 23. Aliment Pharmacol Ther. 2010. PMID: 20955443 Clinical Trial.

4

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.

Cannon CP, Curtis SP, FitzGerald GA, Krum H, Kaur A, Bolognese JA, Reicin AS, Bombardier C, Weinblatt ME, van der Heijde D, Erdmann E, Laine L; MEDAL Steering Committee. Cannon CP, et al. Among authors: kaur a. Lancet. 2006 Nov 18;368(9549):1771-81. doi: 10.1016/S0140-6736(06)69666-9. Lancet. 2006. PMID: 17113426

5

Lower gastrointestinal events in a double-blind trial of the cyclo-oxygenase-2 selective inhibitor etoricoxib and the traditional nonsteroidal anti-inflammatory drug diclofenac.

Laine L, Curtis SP, Langman M, Jensen DM, Cryer B, Kaur A, Cannon CP. Laine L, et al. Among authors: kaur a. Gastroenterology. 2008 Nov;135(5):1517-25. doi: 10.1053/j.gastro.2008.07.067. Epub 2008 Aug 3. Gastroenterology. 2008. PMID: 18823986 Clinical Trial.

6

Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study.

Krum H, Swergold G, Curtis SP, Kaur A, Wang H, Smugar SS, Weir MR, Laine L, Brater DC, Cannon CP. Krum H, et al. Among authors: kaur a. J Hypertens. 2009 Apr;27(4):886-93. doi: 10.1097/HJH.0b013e328325d831. J Hypertens. 2009. PMID: 19516186 Clinical Trial.

7

Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II).

Krueger K, Lino L, Dore R, Radominski S, Zhang Y, Kaur A, Simpson R, Curtis S. Krueger K, et al. Among authors: kaur a. Ann Rheum Dis. 2008 Mar;67(3):315-22. doi: 10.1136/ard.2007.082388. Epub 2007 Oct 27. Ann Rheum Dis. 2008. PMID: 17965424 Clinical Trial.

8

Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial.

Baraf HS, Fuentealba C, Greenwald M, Brzezicki J, O'Brien K, Soffer B, Polis A, Bird S, Kaur A, Curtis SP; EDGE Study Group. Baraf HS, et al. Among authors: kaur a. J Rheumatol. 2007 Feb;34(2):408-20. J Rheumatol. 2007. PMID: 17304660 Clinical Trial.

9

Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study).

Combe B, Swergold G, McLay J, McCarthy T, Zerbini C, Emery P, Connors L, Kaur A, Curtis S, Laine L, Cannon CP. Combe B, et al. Among authors: kaur a. Rheumatology (Oxford). 2009 Apr;48(4):425-32. doi: 10.1093/rheumatology/kep005. Epub 2009 Feb 17. Rheumatology (Oxford). 2009. PMID: 19223284 Clinical Trial.

10

Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.

Krum H, Curtis SP, Kaur A, Wang H, Smugar SS, Weir MR, Laine L, Brater DC, Cannon CP. Krum H, et al. Among authors: kaur a. Eur J Heart Fail. 2009 Jun;11(6):542-50. doi: 10.1093/eurjhf/hfp054. Epub 2009 Apr 19. Eur J Heart Fail. 2009. PMID: 19380329 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,565 results

Search Page

Filters